Unknown

Dataset Information

[Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany].


ABSTRACT:

Background

 Patients at increased risk of inadequate immune response to COVID-19 vaccinations due to their underlying disease or therapy are potentially vulnerable to severe COVID-19 courses. The aim is to assess the population size, clinical courses and hospitalization costs of these patients in Germany.

Methods

 This retrospective cohort study is based on extrapolations of a representative sample of statutory health insurance (SHI) claims data from 2020. Clinical COVID-19 courses, hospitalization costs and durations are compared between the insured group at increased risk for inadequate immune response to COVID-19 vaccinations (risk group) and the insured group without this risk.

Results

 There are approximately 1.82 million SHI-insured individuals in the risk group

SUBMITTER: Hackl D 

PROVIDER: S-EPMC10937099 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature